BRCC vs REGN · rev $391.5M vs P/E 14, rev $14.34B
BRC Inc. (BRCC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
BRC Inc. (BRCC) is a packaged foods company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BRCC revenue for 2024-12-31 was $391.5M. Net income was -$7.6M. Revenue was down 1.0% from 2023-12-31 to 2024-12-31. BRCC currently screens at market cap $129.6M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BRCC currently screens at market cap $129.6M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BRCC and REGN stock pages for the full models.
Not investment advice.